Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Agents for Acute Mountain Sickness in Special Forces
NCT02463357Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Aug 2015
- Primary completion
- Sep 2016
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of quercetin, nifedipine, methazolamide and metformin in acute mountain sickness (AMS), sponsored by University of Colorado Denver. Started Aug 2015; status: completed.
02
Drugs
quercetinnifedipinemethazolamidemetformin
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT02463357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463357.